Correlation Between CRISPR Therapeutics and Salesforce

Can any of the company-specific risk be diversified away by investing in both CRISPR Therapeutics and Salesforce at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CRISPR Therapeutics and Salesforce into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CRISPR Therapeutics AG and salesforce inc, you can compare the effects of market volatilities on CRISPR Therapeutics and Salesforce and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CRISPR Therapeutics with a short position of Salesforce. Check out your portfolio center. Please also check ongoing floating volatility patterns of CRISPR Therapeutics and Salesforce.

Diversification Opportunities for CRISPR Therapeutics and Salesforce

0.55

Correlation Coefficient

CRISPR Therapeutics  Salesforce

Very weak diversification

The 3 months correlation between CRISPR and Salesforce is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding CRISPR Therapeutics AG and salesforce inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on salesforce inc and CRISPR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CRISPR Therapeutics AG are associated (or correlated) with Salesforce. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of salesforce inc has no effect on the direction of CRISPR Therapeutics i.e., CRISPR Therapeutics and Salesforce go up and down completely randomly.

Pair Corralation between CRISPR Therapeutics and Salesforce

Assuming the 90 days trading horizon CRISPR Therapeutics is expected to generate 3.58 times less return on investment than Salesforce. In addition to that, CRISPR Therapeutics is 1.7 times more volatile than salesforce inc. It trades about 0.02 of its total potential returns per unit of risk. salesforce inc is currently generating about 0.1 per unit of volatility. If you would invest  3,548  in salesforce inc on October 11, 2024 and sell it today you would earn a total of  5,533  from holding salesforce inc or generate 155.95% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	97.18%
Values	Daily Returns

CRISPR Therapeutics AG  vs.  salesforce inc

CRISPR Therapeutics

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days CRISPR Therapeutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, CRISPR Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

salesforce inc

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in salesforce inc are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak technical and fundamental indicators, Salesforce sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with CRISPR Therapeutics and Salesforce

The main advantage of trading using opposite CRISPR Therapeutics and Salesforce positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CRISPR Therapeutics position performs unexpectedly, Salesforce can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Salesforce will offset losses from the drop in Salesforce's long position.

The idea behind CRISPR Therapeutics AG and salesforce inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.